Sharon M. Castellino

Our own Dr. @SharonCastelli2 and Dr. Kara Kelly of @RoswellPark published teen cohort results from a landmark phase 3 clinical trial confirming the benefit of a nivolumab combo for advanced Hodgkin lymphoma in @JCO_ASCO. Learn more: choa.org/about-us/newsr….

What happens when patient advocates, healthcare leaders, and AI innovators unite? Magic, and a healthy discussion that drives real innovation. At our Patient Advocacy AI Innovation Lab at #ASH2025, 60% of attendees already use AI tools in their work, yet 54% worry about reliability in cancer care. This tension is where breakthroughs happen. Three key insights emerged: 1) Advocates are essential guides. As Meghan Gutierrez from @lymphoma said: "Meet patients where they are—even if they arrive before we do." Those on the front lines know what will work. 2) Trust must be earned. Verification, transparency, and human oversight aren't optional—they're fundamental. 3) Cross-industry innovation sparks breakthrough thinking. Case studies from Disney, Expedia, and Lemonade helped us reimagine patient onboarding, treatment planning, and friction reduction—while keeping human connection at the center. This is just the beginning. Thank you to our speakers and every advocate who challenged us to think differently. Together, we're ensuring AI serves humanity in the fight against blood cancer.

Interested in learning about the latest topics in pediatric hematology? Our team will be attending and presenting on a variety of topics at @ASH_hematology's 67th Annual Meeting and Exposition, from December 6-9 in Orlando. Learn more: bit.ly/4pEBKmV. #ASH25

Our @JNCI_Now study shows that receiving survivorship care plan, embedded in a comprehensive survivorship program, is associated with improved survival among childhood cancer survivors. @SharonCastelli2 @DrEffinger @JordanGMarchak @WinshipAtEmory @ATLPedsHemOnc @EmoryPediatrics

At @BloodCancerUtd, we're all about the Accelerating Kids' Access to Care Act, so kids with cancer can be about everything else. Watch to learn more about the bill and how it can help kids with cancer ⬇️

The #COGF Newsletter - Summer 2025 is here! This edition covers liquid biopsies, coordinating clinical trials, B+ Foundation philanthropic support, & an interview w/ AYA Chair, Mike Roth. thecogfoundation.org/news.html

Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

Kids with cancer deserve a chance to thrive. But in December, Congress missed a key opportunity to extend programs that incentivize drug companies to find them cures. Learn more about the Give Kids a Chance Act, and how it can help children with cancer ⬇️ statnews.com/2025/04/07/fda…

#AACR25 Honored to co-chair (with Mimi Bondopadhayay) great science - mini symposium on #Pediatric Advances_Bench to Bedside.

Check out the latest findings from @NavigatorSurvey, which found that an overwhelming number of Americans want the healthcare tax credit extended and would back members of Congress who do so ⬇️ americanscovered.org/new-survey-ame… #NoHealthcareCuts

Members of Congress are now back in their home districts for a 2-week spring recess. Check the websites of your Senators and Rep to find out if there are events happening near you that might give you the chance to speak up about #ChildhoodCancer issues like NCI funding.

The #COGF Newsletter - Spring 2025 is here! This edition covers the road from idea to clinical trial, a foundations philanthropic support for kidney cancer research, an interview w/ Renal Chair, Nicholas Cost, & a letter from our Group Chair, Doug Hawkins. thecogfoundation.org/news.html

@mcuban Thank you Mark Cuban. Our pediatric oncology social workers turn to #costplus often. …And yes research in the US has led massive advances for children with cancer, infectious diseases, and many rare diseases.

You probably should do your homework. We have one of the most advanced robotics factory in the country. We make things like drugs for kids with cancer that they can’t get elsewhere , biosimilars and drugs that are in shortage and sell them at an affordable price. We are expanding as we speak so we can do more and more. What do you do ?

Some in Congress are rushing to cut $880B from #Medicaid. These cuts will terminate healthcare for 10M people, including blood cancer patients. Without coverage, many will not be able to afford care. Tell your Senator to oppose Medicaid cuts ⬇️ advocacy.lls.org/a/protect-medi…

ASH and 90+ Organizations Call for HHS to Immediately Restore CDC’s Division of Blood Disorders. Without it, patients with blood diseases face preventable risks. ASH is calling for its restoration. 🔗 ow.ly/gYnz50VwYph #Fight4Hematology

Working to support #AYA patients from diagnosis through survivorship @ATLPedsHemOnc with treatment, supportive care and policy advocacy

@lab_rezvani @EladSharonMD @NatureMedicine Congratulations Katy. Look forward to seeing this work advance to trials inclusive of adolescents.

Please check out our paper published in @NatureMedicine on our Phase I trial of AFM13-precomplexed cord blood NK cells in relapsed/refractory CD30+ lymphomas. Led by Dr. Yago Nieto and an outstanding team of coauthors and collaborators, this study marks the first clinical demonstration of NK cell redirection using a bispecific engager. We report an ORR of 92.9% and CR of 66.7% in 42 patients with a median of 7 prior therapies and show that this approach is safe and may serve as a bridge to SCT. Excited to move forward with our next generation engineered NK cells in combination with engagers and mAbs. #CancerResearch #Immunotherapy #NKcells @MDAndersonNews

ASH decries HHS restructuring and CDC layoffs. The Blood Disorders Division addresses SCD, thrombosis, hemophilia, thalassemia, and more. Millions' health is at stake; ASH urges immediate action. #Fight4Hematology

It's #AYACancerWeek. Did you know that lymphoma is responsible for nearly 1 in 5 cancer diagnoses in young people? This week, we'll share stories from AYA patients, resources designed uniquely for them, & updates on how we're supporting the AYA community: lymphoma.org/understanding-…

We are so excited to share that the DoD CDMRP has allocated $75 M to fund 34 research awards for cancers affecting children, adolescents and young adults as part of the FY24 budget. Your voice matters. 💛 #ChildhoodCancer #RallyOn